{
    "clinical_study": {
        "@rank": "151338", 
        "arm_group": [
            {
                "arm_group_label": "Isotretinoin capsules, 40 mg", 
                "arm_group_type": "Experimental", 
                "description": "Isotretinoin Capsules, 40 mg of Dr.Reddy's Laboratories Ltd"
            }, 
            {
                "arm_group_label": "ACCUTANE", 
                "arm_group_type": "Active Comparator", 
                "description": "ACCUTANE 40 mg of Roche Laboratories Inc"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine the pharmacokinetics and bioequivalence of\n      isotretinoin formulations after administration of single doses to normal,\n      non-smoking,healthy males under fasting conditions"
        }, 
        "brief_title": "Bioequivalence Study of Isotretinoin Capsules 40 mg Under Fasting Condition", 
        "completion_date": {
            "#text": "September 2001", 
            "@type": "Actual"
        }, 
        "condition": "Healthy", 
        "detailed_description": {
            "textblock": "An open label, randomized, two-treatment, single dose, oral bioequivalence study of\n      Isotretinoin capsules 40 mg of Dr. Reddy's Laboratories Limited,under fasting conditions"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Healthy males between 18 and 45 years of age inclusive.\n\n          2. Informed of the nature of the study and given written informed consent.\n\n          3. Have a body weight within 15% of the appropriate range as defined in the 1983\n             Metropolitan Life Company tables and weighing at least 125 lbs. (Appendix I).\n\n        Exclusion Criteria\n\n          1. Hypersensitivity to isotretinoin or related compounds.\n\n          2. Any history of a clinical condition which might affect drug absorption, metabolism or\n             excretion.\n\n          3. Recent history of mental illness, drug addiction, drug abuse or alcoholism.\n\n          4. Donation of greater than 500 ml of blood in the past 4 weeks prior to study dosing or\n             difficulty in donating blood.\n\n          5. Received an investigational drug within the 4 weeks prior to study dosing.\n\n          6. Currently taking any prescription medication within the 7 days prior to study dosing\n             or over-the-counter medication within 3 days of study dosing. This prohibition does\n             not include vitamins or herbal preparations taken as nutritional supplements for\n             non-therapeutic indications as judged by the attending physician.\n\n          7. Regular tobacco use in the 3 months prior to study dosing."
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "35", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01888289", 
            "org_study_id": "AAI-US-101"
        }, 
        "intervention": {
            "arm_group_label": [
                "Isotretinoin capsules, 40 mg", 
                "ACCUTANE"
            ], 
            "description": "Isotretinoin Capsules,40 mg", 
            "intervention_name": "Isotretinoin", 
            "intervention_type": "Drug", 
            "other_name": "ACCUTANE"
        }, 
        "intervention_browse": {
            "mesh_term": "Isotretinoin"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "June 26, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Quadrangle Drive, Chapel Hill,", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "27514"
                }, 
                "name": "AAI"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "An Open Label, Randomized, Single Dose, Oral Bioequivalence Study of Isotretinoin Capsules 40 mg of Dr. Reddy's Laboratories Limited, India Comparing With That of ACCUTANE\u00ae Capsules 40 mg of Roche Laboratories Inc., Under Fasting Conditions", 
        "overall_official": {
            "affiliation": "AAI", 
            "last_name": "Dr. Ralph Scallion , MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "August 2001", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Area under curve (AUC)", 
            "safety_issue": "No", 
            "time_frame": "Pre-dose (0) and 0.5, 1,2,3,4,5,6,8,10,16,24,36,48,72 and 96hrs"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01888289"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Dr. Reddy's Laboratories Limited", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Dr. Reddy's Laboratories Limited", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2001", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2001"
    }
}